What companies are MESO's competitors?

Mesoblast Limited (MESO)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.

How does MESO compare to its peers?

The peer comparison table on this page shows Mesoblast Limited (MESO) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.

What sector does MESO operate in?

Mesoblast Limited (MESO) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

MESO

Mesoblast Limited

NASDAQ·Biotechnology · Healthcare

$16.42$0.21−1.26%

After hours·$16.42+0.00%

Market cap$2.13B·Market closed·Jul 21 8:00 PM UTC

Frequently Asked Questions About MESO

What companies are MESO's competitors?: Mesoblast Limited (MESO)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does MESO compare to its peers?: The peer comparison table on this page shows Mesoblast Limited (MESO) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does MESO operate in?: Mesoblast Limited (MESO) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

MESO

Mesoblast Limited

NASDAQ·Biotechnology · Healthcare

$16.42$0.21−1.26%

After hours·$16.42+0.00%

Market cap$2.13B·Market closed·Jul 21 8:00 PM UTC

Peers


IBRX	ImmunityBio, Inc.	$8.07	$8.5B
LQDA	Liquidia Corporation	$80.89	$7.2B
COGT	Cogent Biosciences, Inc.	$39.64	$6.8B
EWTX	Edgewise Therapeutics, Inc.	$39.58	$4.3B
GPCR	Structure Therapeutics Inc.	$49.35	$2.8B
QURE	uniQure N.V.	$40.09	$2.7B
NUVB	Nuvation Bio Inc.	$6.43	$2.2B
OCUL	Ocular Therapeutix, Inc.	$8.93	$2.0B
GLPG	Galapagos N.V.	$27.98	$1.8B
VRDN	Viridian Therapeutics, Inc.	$19.18	$1.7B

Frequently Asked Questions About MESO

What companies are MESO's competitors?: Mesoblast Limited (MESO)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does MESO compare to its peers?: The peer comparison table on this page shows Mesoblast Limited (MESO) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does MESO operate in?: Mesoblast Limited (MESO) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.